BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8911748)

  • 1. Imidazoline binding sites and signal transduction pathways.
    Musgrave IF; Krautwurst D; Schultz G
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):990-4. PubMed ID: 8911748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling.
    Musgrave IF; Hughes RA
    J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells.
    Musgrave IF; Krautwurst D; Hescheler J; Schultz G
    Ann N Y Acad Sci; 1995 Jul; 763():272-82. PubMed ID: 7545885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targets and techniques in imidazoline receptor research.
    Musgrave IF; Hughes RA
    Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazoline binding sites on PC12 cells and bovine chromaffin cells.
    Steffen G; Dendorfer A; Dominiak P
    Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I1-imidazoline receptors: an update.
    Bousquet P; Dontenwill M; Greney H; Feldman J
    J Hypertens Suppl; 1998 Aug; 16(3):S1-5. PubMed ID: 9747903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.
    Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R; Olmos G; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
    Olmos G; Kulkarni RN; Haque M; MacDermot J
    Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla.
    Regunathan S; Meeley MP; Reis DJ
    Biochem Pharmacol; 1993 Apr; 45(8):1667-75. PubMed ID: 8387303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic effects of imidazoline derivatives are not mediated via imidazoline binding sites but alpha1-adrenergic receptors.
    Raasch W; Chun KRJ ; Dendorfer A; Dominiak P
    Jpn J Pharmacol; 2000 Sep; 84(1):1-6. PubMed ID: 11043446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of new cirazoline derivative to imidazoline receptors from human brain.
    Dontenwill M; Ehrhardt JD; Senecheau P; Molines A; Greney H; Bousquet P
    Neurochem Int; 1997 Jan; 30(1):9-16. PubMed ID: 9116592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla.
    Ernsberger P; Haxhiu MA
    Am J Physiol; 1997 Nov; 273(5):R1572-9. PubMed ID: 9374796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.
    Olmos G; Alemany R; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1994 Apr; 111(4):997-1002. PubMed ID: 8032628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes.
    Hosseini AR; King PR; Louis WJ; Gundlach AL
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.